4//SEC Filing
Sander Dale A. 4
Accession 0001818382-24-000165
CIK 0001818382other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:45 PM ET
Size
9.1 KB
Accession
0001818382-24-000165
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Sander Dale A.
CFO and Chief Corp. Deve. Off.
Transactions
- Exercise/Conversion
Common Stock
2024-08-27$2.56/sh+39,389$100,836→ 41,389 total - Exercise/Conversion
Stock Options (right to buy)
2024-08-27−39,389→ 0 totalExercise: $2.56From: 2018-09-01Exp: 2025-09-01→ Common Stock (39,389 underlying) - Sale
Common Stock
2024-08-27$6.68/sh−39,389$263,119→ 2,000 total
Holdings
- 20,600(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $6.67 to $6.725. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001878193
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 6:45 PM ET
- Size
- 9.1 KB